Northstar Asset Management Inc. grew its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 20.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,191 shares of the company’s stock after acquiring an additional 703 shares during the quarter. Northstar Asset Management Inc.’s holdings in Procter & Gamble were worth $668,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. MOKAN Wealth Management Inc. increased its holdings in shares of Procter & Gamble by 13.7% during the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock valued at $2,442,000 after acquiring an additional 1,846 shares in the last quarter. Benjamin Edwards Inc. increased its holdings in shares of Procter & Gamble by 120.7% during the first quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock valued at $62,098,000 after acquiring an additional 199,258 shares in the last quarter. Capital Investment Advisory Services LLC grew its holdings in Procter & Gamble by 13.8% during the first quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock worth $6,426,000 after buying an additional 4,562 shares in the last quarter. World Investment Advisors grew its holdings in Procter & Gamble by 6.0% during the first quarter. World Investment Advisors now owns 50,913 shares of the company’s stock worth $8,677,000 after buying an additional 2,886 shares in the last quarter. Finally, Concurrent Investment Advisors LLC grew its holdings in Procter & Gamble by 26.4% during the first quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock worth $20,451,000 after buying an additional 25,059 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In other news, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the transaction, the chief operating officer owned 28,036 shares in the company, valued at approximately $4,409,221.72. This represents a 31.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider owned 182,422 shares of the company’s stock, valued at $28,689,507.94. The trade was a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 in the last three months. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Stock Up 0.3%
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. The company had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be paid a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio is presently 64.98%.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on PG. Raymond James Financial decreased their price target on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a report on Monday, October 20th. JPMorgan Chase & Co. decreased their price target on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a report on Friday, October 10th. Bank of America decreased their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. BNP Paribas reiterated an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. Finally, BNP Paribas Exane reduced their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $171.68.
Get Our Latest Stock Report on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- What Makes a Stock a Good Dividend Stock?
- Time to Take Notice: PEGA’s GenAI Blueprint Delivers Huge Q3 Beat
- Investing in Travel Stocks Benefits
- MarketBeat Week in Review – 10/20 – 10/24
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
